Luliconazole, trade names Luzu among others, is an imidazole antifungal medication.[2] As a 1% topical cream, It is indicated for the treatment of athlete's foot, jock itch, and ringworm caused by dermatophytes such as Trichophyton rubrum, Microsporum gypseum,[3] and Epidermophyton floccosum.[1]
 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Luzu, Luzarn, Lulicon, LULY, Zyluli,Luris |
| Routes of administration | Topical |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | >99%[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H9Cl2N3S2 |
| Molar mass | 354.27 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
References
edit- ^ a b "LUZU (luliconazole) Cream, 1%. Full Prescribing Information" (PDF). Valeant Pharmaceuticals North America LLC. Retrieved 1 October 2015.
- ^ Gupta AK, Daigle D (2016). "A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections". Infection and Drug Resistance. 9: 1–6. doi:10.2147/IDR.S61998. PMC 4723097. PMID 26848272.
- ^ "FDA approves luliconazole for tinea pedis". November 19, 2013. Archived from the original on 16 January 2014. Retrieved 14 January 2014.
External links
edit
Media related to Luliconazole at Wikimedia Commons
 | This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |